These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 28135101

  • 1. Design and Investigation of a [18F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging.
    Yang D, Comeau A, Bowen WD, Mach RH, Ross BD, Hong H, Van Dort ME.
    Mol Pharm; 2017 Mar 06; 14(3):770-780. PubMed ID: 28135101
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of 4 and 6-carbon spacer conformationally flexible tetrahydroisoquinolinyl benzamide analogues for imaging the sigma-2 receptor status of solid tumors.
    Lee I, Lieberman BP, Li S, Hou C, Makvandi M, Mach RH.
    Nucl Med Biol; 2016 Nov 06; 43(11):721-731. PubMed ID: 27589334
    [Abstract] [Full Text] [Related]

  • 3. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.
    Tu Z, Xu J, Jones LA, Li S, Dumstorff C, Vangveravong S, Chen DL, Wheeler KT, Welch MJ, Mach RH.
    J Med Chem; 2007 Jul 12; 50(14):3194-204. PubMed ID: 17579383
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
    John CS, Gulden ME, Li J, Bowen WD, McAfee JG, Thakur ML.
    Nucl Med Biol; 1998 Apr 12; 25(3):189-94. PubMed ID: 9620622
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.
    Nucl Med Biol; 2013 Nov 12; 40(8):1025-34. PubMed ID: 23969085
    [Abstract] [Full Text] [Related]

  • 6. Development of 18F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior.
    Potemkin R, Strauch B, Kuwert T, Prante O, Maschauer S.
    Mol Pharm; 2020 Mar 02; 17(3):933-943. PubMed ID: 32011889
    [Abstract] [Full Text] [Related]

  • 7. Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer.
    Zhou D, Xu J, Mpoy C, Chu W, Kim SH, Li H, Rogers BE, Katzenellenbogen JA.
    Nucl Med Biol; 2018 Nov 02; 66():26-31. PubMed ID: 30195072
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
    Selivanova SV, Toscano A, Abate C, Berardi F, Müller A, Krämer SD, Schibli R, Ametamey SM.
    Nucl Med Biol; 2015 Apr 02; 42(4):399-405. PubMed ID: 25637276
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.
    Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Ponnala S, Babich JW.
    Eur J Nucl Med Mol Imaging; 2017 Apr 02; 44(4):647-661. PubMed ID: 27847991
    [Abstract] [Full Text] [Related]

  • 10. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
    John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD.
    Cancer Res; 1999 Sep 15; 59(18):4578-83. PubMed ID: 10493511
    [Abstract] [Full Text] [Related]

  • 11. 18 F-Labeled benzylpiperazine derivatives as highly selective ligands for imaging σ1 receptor with positron emission tomography.
    Ye J, Wang L, Deuther-Conrad W, Chen Y, Zhang X, Zhang J, Huang Y, Brust P, Jia H.
    J Labelled Comp Radiopharm; 2019 Jun 30; 62(8):425-437. PubMed ID: 30991462
    [Abstract] [Full Text] [Related]

  • 12. Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand.
    Moldovan RP, Gündel D, Teodoro R, Ludwig FA, Fischer S, Toussaint M, Schepmann D, Wünsch B, Brust P, Deuther-Conrad W.
    Int J Mol Sci; 2021 May 21; 22(11):. PubMed ID: 34064122
    [Abstract] [Full Text] [Related]

  • 13. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.
    Bioconjug Chem; 2008 Dec 21; 19(12):2462-70. PubMed ID: 19053298
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY, Wang X, Zhang JM, Deuther-Conrad W, Zhang XJ, Huang Y, Li Y, Ye JJ, Cui MC, Steinbach J, Brust P, Liu BL, Jia HM.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5270-8. PubMed ID: 25189691
    [Abstract] [Full Text] [Related]

  • 15. Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging.
    Liu T, Liu C, Xu X, Liu F, Guo X, Li N, Wang X, Yang J, Yang X, Zhu H, Yang Z.
    J Nucl Med; 2019 Sep 01; 60(9):1284-1292. PubMed ID: 30796170
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
    Kawamura K, Tsukada H, Shiba K, Tsuji C, Harada N, Kimura Y, Ishiwata K.
    Nucl Med Biol; 2007 Jul 01; 34(5):571-7. PubMed ID: 17591557
    [Abstract] [Full Text] [Related]

  • 17. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL, Franssen GM, van Weerden WM, McBride WJ, Laverman P, de Blois E, Hajjaj B, Brunel L, Goldenberg DM, Fehrentz JA, Martinez J, Boerman OC, de Jong M.
    J Nucl Med; 2014 Dec 01; 55(12):2050-6. PubMed ID: 25413139
    [Abstract] [Full Text] [Related]

  • 18. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
    John CS, Lim BB, Vilner BJ, Geyer BC, Bowen WD.
    J Med Chem; 1998 Jul 02; 41(14):2445-50. PubMed ID: 9651150
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent.
    Moussa IA, Banister SD, Giboureau N, Meikle SR, Kassiou M.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6820-3. PubMed ID: 21962578
    [Abstract] [Full Text] [Related]

  • 20. Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging.
    Cardinale J, Schäfer M, Benešová M, Bauder-Wüst U, Leotta K, Eder M, Neels OC, Haberkorn U, Giesel FL, Kopka K.
    J Nucl Med; 2017 Mar 15; 58(3):425-431. PubMed ID: 27789722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.